. Archives of Disease in Childhood, 51, 763. Extrahepatic biliary atresia versus neonatal hepatitis: review of 137 prospectively investigated infants. In a prospective regional survey of neonatal hepatitis syndrome 32 infants had extrahepatic biliary atresia (EHBA) and 103 had hepatitis. No cause for the lesion was found in infants with extrahepatic biliary atresia, but in 32 with hepatitis a specific cause was identified, 24 having genetic deficiency of the serum protein oc1-antitrypsin. No differences were observed in parental age, mother's health in pregnancy, month of birth, birth order, or sex of the infants. Familial idiopathic hepatitis occurred in 3 of 67 sibs of patients with idiopathic hepatitis, but the 33 sibs of EHBA patients had no liver disease. Of the infants with hepatitis, 36 were of low birthweight, <2-5 kg, and 23 were born prematurely. Infants with biliary atresia were all of normal birthweight and only one was born prematurely.
that the former are abnormal a primary failure of development of the bile ducts seems unlikely. Further, the degree of duct involvement is very variable (Alagille, 1972;  Strauss, Valderrama, and Alpert, 1972; Landing, 1974) , which is difficult to explain on the basis of a single antenatal insult or abnormality in organogenesis. Also, in some infants with classical extrahepatic biliary atresia there is evidence that the bile ducts were previously intact (Holden, 1964; Poley et al., 1972; Danks, 1974) . The more likely pathogenesis, therefore, is that the condition results from a sclerosing inflammatory lesion initiated in the bile duct epithelium and involving part or all of the biliary tract, starting late in fetal life, or early in postnatal life. The aetiology is unknown. It has been suggested that both neonatal hepatitis and EHBA may be due to the same basic disease process with the major damage occurring in some instances in the bile ducts (Alagille, 1972; Strauss et al., 1972; Landing, 1974) . We report an analysis of data collected during a prospective study of (Porter et al., 1972) of the neonatal hepatitis syndrome.
This was defined for the purpose of the study as a conjugated hyperbilirubinaemia starting within the first 4 months of life and accompanied by biochemical and pathological evidence of hepatocellular necrosis. This, therefore, includes both patients with EHBA and those with intrahepatic disease or hepatitis, but with patent biliary passages. Final proof of EHBA was obtained in all instances at laparotomy. In all cases known genetic, metabolic, infectious, or environmental causes of the neonatal hepatitis syndrome were fully investigated. Those patients with hepatitis in whom no causative agent was identified or in whom the association with the putative cause was tenuous, for example, sepsis or a rise in cytomegalovirus antibody titre in the serum without recovery of the cytomegalovirus from liver tissue, were classified as idiopathic hepatitis.
Standard laboratory methods were used to determine serum bilirubin, aspartate aminotransferase, alkaline phosphatase, and prothrombin time. Percutaneous liver biopsies were performed using the Menghini technique. (Campbell et al., 1974b in patients with EHBA. The remaining 71 patients with hepatitis are considered idiopathic, though 9 of these had conditions which may be associated with hepatitis but which were not definitely causative in these patients (chromosomal trisomy, 4; sepsis, 3; cystic fibrosis, 2; halothane, 1). One other infant in this idiopathic hepatitis group was shown to have hypoplasia of intrahepatic bile ducts and normal extrahepatic ducts at laparotomy.
There may have been other infants in the series with similar pathologies in whom jaundice cleared and therefore did not come to surgery and wedge biopsy of the liver.
Comparison of factors of possible aetiological importance. When findings in patients with EHBA are compared with those of the hepatitis cases, no seasonal variation in the month of birth was found (Fig.) Table II , one child with EHBA had a gestation of <37 weeks, and only one mature child was light-for-gestational age; whereas in the hepatitis group a significantly greater number of infants had short gestations (P<0 005). None of these infants with EHBA weighed less than 2 *5 g at birth, in contrast to the 35% of infants in the complete hepatitis group and 39% of those with idiopathic hepatitis who had a birthweight of less than 2 5 g (P <0 005).
Chromosomal abnormalities were present only in the hepatitis patients, 4 of whom had trisomy. Identifiable congenital abnormalities such as congenital heart disease, meningomyeloceles, and cleft palate, and significant clinical disorders outside the gastrointestinal system occurred more commonly in hepatitis than in EHBA.
Clinical features. Jaundice had started in the first 2 weeks of life in 80% of those with EHBA as opposed to only 68% of those with hepatitis. In 6 patients with EHBA, however, jaundice was first noted at varying times between the third and 3LE II (Table III) . 83% of those with EHBA were recorded as having acholic stools in the first 2 months of life as opposed to 52% of those with hepatitis and 41% of those with idiopathic hepatitis (P <0 005).
There were no significant differences in the frequency of abnormal physical features in the three groups except hepatomegaly (a liver edge palpable more than 5 cm below the costal margin), which occurred more commonly in EHBA than in the hepatitis group (P<0 05). Splenomegaly, or at least palpable splenic enlargement, was also more common in this group.
Comparison of liver function tests in the first 2 months of life showed considerable overlap between the three groups, but serial determinations of serum bilirubin concentrations showed that a steady fall occurred only in hepatitis and that a stable bilirubin was significantly more common in EHBA (P < 0* 005). In both EHBA and hepatitis, however, a progressive rise in bilirubin or fluctuations of serum bilirubin concentration of more than 51 ,umol/l (3 mg/100 ml) occurred with equal frequency. A direct reacting bilirubin of 68 ,umol/l (4 mg/ 100 ml) was found significantly more frequently in EHBA (P<0001) but the frequency of serum bilirubin levels of > 235 ±mol/l (15 mg/ 100 ml) was similar in the two groups (Table IV) Liver biopsy interpretation. In 15 of the 20 infants with EHBA who had percutaneous liver biopsies the histological abnormalities were suggestive or diagnostic of EHBA (Table V) . EHBA Both those with high excretion were females and in one of these the test was repeated during cholestyramine admininstration with excretion falling from 11-2 to 7%. 13 patients in whom excretion was <10% on first testing but in whom the biopsy appearances were those of hepatitis, or were only suggestive of extrahepatic biliary atresia, also had repeat excretion determined during cholestyramine administration and in all of these the excretion remained <10%.
These findings are to be contrasted with the excretion in hepatitis which was > 10% in 13 of 18 infants. Of the 5 who excreted < 100%, 2 excreted 17 and 31 % on repeat testing during cholestyramine administration, jaundice subsequently cleared completely, and they were not subjected to laparotomy. Excretion remained persistently low (5%) during cholestyramine administration in 2 patients who at laparotomy had patent extrahepatic ducts; one had severe hepatitis and cirrhosis, the other intrahepatic biliary hypoplasia. The remaining child proceeded to laparotomy without repeat testing and was found to have intact extrahepatic bile ducts.
Results of operative management. In only 3 of the 32 patients with EHBA was bile drainage established. One patient had distal atresia with patent proximal extrahepatic bile ducts which contained bile and allowed cholecystenterostomy to be carried out. Subsequently, jaundice remitted and liver function returned to normal, and at follow-up at 8 months of age this child is clinically and biochemically normal. The other 2 had a hepatic portoenterostomy. In this procedure the portahepatis is explored, residual bile ducts are removed, together with any fibrous tissue in the portahepatis, and an anastamosis fashioned between the portahepatis and a Roux-en-Y loop from the jejunum. In both of these children effective biliary drainage was established in operations at 5 months of age. Both however had subsequent intermittent attacks of jaundice and fever due to cholangitis, with persistently abnormal liver function tests and icterus at 33 months in one and clinical features of cirrhosis already at the age of 26 months in the other. The same operation carried out in 13 others produced no clinical or biochemical improvement, but in only 4 was portoenterostomy carried out before 70 days of age. In 2 patients hepatic bile ducts were anastamosed to bowel, one had a cholecystenterostomy, and one a hepatic lymphaticojejunostomy, all without apparent benefit to the patient.
Eight who had attempted anastomosis of liver or bile duct to bowel are dead, the mean age of death being 11 * 6 months (range 2-27 months). None of the patients with EHBA were shown to have any of the recognized specific infectious or metabolic causes of hepatitis. Thus, systematic screening for such causes which is essential since specific treatment may be required, is also of value in limiting patients in whom EHBA must be considered. It is particularly important to examine for ocl-antitrypsin deficiency, which is found in 2500 of the hepatitis patients in this series, particularly since histological features may mimic atresia (Porter et al., 1972) . Unless this condition and biliary atresia are mutually exclusive both could occur in the same patient, but this has not yet been recorded. The extrahepatic biliary hypoplasia recorded in some infants with al-antitrypsin deficiency is thought to be due to diminished bile secretion rather than a primary disease process affecting extrahepatic bile ducts. (Porter et al., 1972; Christen, Bau, and Halsband, 1975) . Unfortunately, indirect methods of diagnosing EHBA, such as the ratio of serum bile salts (Javitt et al., 1973) , red cell haemolysis test (Lubin et al., 1971) , and serum ao-fetoprotein concentration (Zeltzef et al., 1974) , which have been claimed to be or discriminatory value, have not been confirmed in practice (Manthrope and Mowat 1975; Mowat, 1973; Johnston et al., 1976) . The safety and value of percutaneous liver biopsy in distinguishing patients with EHBA from those with hepatitis is well illustrated in this study. By the early use of this technique a diagnosis of hepatitis is confirmed in a large percentage of cases. In the majority of patients with EHBA the correct diagnosis was made. Nevertheless, in a number of instances the biopsy was not considered suggestive of EHBA though this proved to be the correct diagnosis, a difficulty reported by other authors (Alagille, 1972; Thaler and Gellis, 1968) . In this series the timing of percutaneous liver biopsy in relation to the duration of jaundice did not seem to influence significantly the correct histological diagnosis of EHBA.
We have used the Rose Bengal faecal excretion test primarily to confirm liver biopsy findings where they have been diagnostic or suggestive of EHBA, or in instances in which persistent jaundice and acholic stools have made this diagnosis a possibility even though the biopsy appearances were not typical. We have repeated the test during cholestyramine administration when the biopsy was not diagnostic and confirmed that a persistently low excretion is of value in distinguishing patients with extrahepatic biliary obstruction from those with patent ducts. In this study the distinction, however, was not complete as had been previously reported (Campbell et al., 1974b (1968) , that laparotomy and careful examination of extrahepatic biliary system caused an increased incidence of cirrhosis in neonatal hepatitis, have not been refuted and remain a powerful argument against the unnecessary use of laparotomy to detect remedial lesions of the biliary tract.
The disappointing results of surgical intervention, including portoenterostomy, in this series are similar to those recently reported by Campbell et al. (1974a) . Ineffective surgery in this series did not cause increased morbidity or significantly earlier death. Although successful biliary drainage was achieved in 2 patients operated on at 5 months of age, both rapidly developed advanced liver disease as occurred in the patients reported by Danks et al. (1974) . In all of these series surgery was carried out after 3 months of age in most infants. These poor results must be contrasted with the most recent reports with high short-term success rates from North American clinics (Lilley and Altman, 1975) , and particularly the Japanese studies of Kasai et al. (1975) . The latter workers reported improved biliary excretion in 19 of 59 patients with complete extrahepatic biliary atresia in whom portoenterostomy was performed before 16 weeks of age. Jaundice cleared in 11 of these patients, 10 were thought to be 'cured', one for 17 years after operation. Even more remarkable is the finding that in 7 of 8 infants operated on before the age of 70 days jaundice cleared completely. Major surgical problems which have to be resolved include the prevention of ascending cholangitis and detection of secondary obstruction to bile flow occurring after successful hepatic portoentrostomy, usually due to local factors at the anastomotic site. The main modifications introduced to overcome these difficulties usually involve a cutaneous enterostomy which allows observation of bile drainage, and lengthening or increasing the complexity of the Roux-en-Y loop anastomosed to the liver (Kasai et al., 1975; Lilley and Altman, 1975 (Mason, Northway, and Kohn, 1966) . It is essential therefore that such cases be operated on in centres where there is the necessary expertise available, both in making a presumptive diagnosis and in assessing the condition of the bile ducts at laparotomy.
From the present study no clues emerge as to what initiates extrahepatic biliary atresia. Males predominated in this series, but as in other reports (Alagille, 1972 ) the sex incidence was not significant. Neither seasonal factors, adverse factors in the pregnancy or perinatal period, nor birth order have been implicated in this study. Nor could the condition be related to the age of the parents, as reported from Hawai and Japan (Shim, Kasai, and Spence, 1974) in a study which also suggested that familial cases occurred and that the birthweights in biliary atresia were low. This was not confirmed in the present series in which prematurity and low birthweight was a feature of the hepatitis group only. The exact reason for the poor intrauterine growth in the hepatitis cases was rarely identified, but such reduction in intrauterine growth is commonly found in fetuses subjected to a massive prenatal insult, such as rubella embryopathy. There is thus no evidence that the patients with extrahepatic biliary atresia were subjected to such a cause, and it seems that the adverse factor or factors which affect only the bile ducts must be very selective whether it operates antenatally or only postnatally. Our observation that in 6 of 32 infants jaundice was not observed until the third week of life supports the contention that the lesion is acquired rather than congenital in some patients at least. These observations provide a basis for hoping that in some cases removing the diseased extrahepatic bile ducts may allow the liver to function normally, and cause us to be cautiously optimistic about the place of hepatic portoenterostomy in the management of biliary atresia. 
